These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31019876)

  • 1. Immunological Alterations due to Hemodialysis Might Interfere with Early Complications in Renal Transplantation.
    Mai K; Boldt A; Hau HM; Kirschfink M; Schiekofer S; Keller F; Beige J; Giannis A; Sack U; Rasche FM
    Anal Cell Pathol (Amst); 2019; 2019():8389765. PubMed ID: 31019876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The difference of T cell phenotypes in end stage renal disease patients under different dialysis modality.
    Xiaoyan J; Rongyi C; Xuesen C; Jianzhou Z; Jun J; Xiaoqiang D; Xiaofang Y
    BMC Nephrol; 2019 Aug; 20(1):301. PubMed ID: 31383007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-transplant immune state defined by serum markers and alloreactivity predicts acute rejection after living donor kidney transplantation.
    Vondran FW; Timrott K; Kollrich S; Steinhoff AK; Kaltenborn A; Schrem H; Klempnauer J; Lehner F; Schwinzer R
    Clin Transplant; 2014 Sep; 28(9):968-79. PubMed ID: 24931031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release of soluble CD30 after allogeneic stimulation is mediated by memory T cells and regulated by IFN-γ and IL-2.
    Velásquez SY; García LF; Opelz G; Alvarez CM; Süsal C
    Transplantation; 2013 Jul; 96(2):154-61. PubMed ID: 23857000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
    Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
    Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory, degenerative and vascular lesions in long-term dialysed patients.
    Vrabie CD; Petrescu A; Waller M; Cojocaru M; Ciocâlteu A; Dina I
    Rom J Intern Med; 2009; 47(2):149-59. PubMed ID: 20067165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of CD4
    McRae JL; Chia JS; Pommey SA; Dwyer KM
    Nephrology (Carlton); 2017 Jul; 22(7):505-512. PubMed ID: 27517975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretransplant low CD3+CD25high cell counts or a low CD3+CD25high/CD3+HLA-DR+ ratio are associated with an increased risk to acute renal allograft rejection.
    Hueso M; Mestre M; Benavente Y; Bas J; Grinyó JM; Navarro E
    Transplantation; 2011 Sep; 92(5):536-42. PubMed ID: 21849930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-year immunological evaluation of chronic hemodialysis in end-stage renal disease patients.
    Meier P; von Fliedner V; Markert M; van Melle G; Deppisch R; Wauters JP
    Blood Purif; 2000; 18(2):128-37. PubMed ID: 10838472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of a single hemodialysis procedure on human T lymphocytes.
    Lisowska KA; Pindel M; Pietruczuk K; Kuźmiuk-Glembin I; Storoniak H; Dębska-Ślizień A; Witkowski JM
    Sci Rep; 2019 Mar; 9(1):5041. PubMed ID: 30911040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of hemodialysis on circulating CD4(low)CD25 (high) regulatory T cells in end-stage renal disease patients.
    Lisowska KA; Dębska-Ślizień A; Jasiulewicz A; Bryl E; Witkowski JM
    Inflamm Res; 2014 Feb; 63(2):99-103. PubMed ID: 24189710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of peripheral blood natural killer cells, T-cell helper/T-cell suppressor ratio and intercurrent infection frequency in hepatitis C seropositive prevalent hemodialysis patients.
    Ibrahim MA; Mostafa AA; El-Said HW; Mohab AM; Hebah HA
    Hemodial Int; 2014 Oct; 18 Suppl 1():S23-31. PubMed ID: 25330828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of urinary CD4⁺ and CD8⁺ T cells in kidney transplantation patients with polyomavirus BK infection and allograft rejection.
    van Doesum WB; Abdulahad WH; van Dijk MC; Dolff S; van Son WJ; Stegeman CA; Sanders JS
    Transpl Infect Dis; 2014 Oct; 16(5):733-43. PubMed ID: 25092256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated and regulatory T lymphocyte populations in chronic hemodialysis patients.
    Rabb H; Agosti SJ; Pollard S; Bittle PA; Ramirez G
    Am J Kidney Dis; 1994 Sep; 24(3):443-52. PubMed ID: 7915875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the frequencies and functions of CD4
    Zare M; Namavar Jahromi B; Gharesi-Fard B
    J Reprod Immunol; 2019 Jun; 133():43-51. PubMed ID: 31255887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttransplant soluble CD30 as a predictor of acute renal allograft rejection.
    Kamali K; Abbasi MA; Farokhi B; Abbasi A; Fallah P; Seifee MH; Ghadimi N; Rezaie AR
    Exp Clin Transplant; 2009 Dec; 7(4):237-40. PubMed ID: 20353374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of erythropoietin on immunological system of patients with chronic renal failure].
    Debska-Slizień A; Rutkowski B; Manitius J; Zdrojewski Z; Szołkiewicz M; Bułło B; Lizakowski S; Myśliwska J; Myśliwski A; Bryl E; Trzonkowski P; Bakowska A; Rachoń D
    Pol Merkur Lekarski; 2003 Oct; 15(88):326-7; discussion 327-9. PubMed ID: 14974359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic Monitoring of T-Lymphocyte Subsets and Hla-Dr-Positive Monocytes in Kidney Transplant Recipients: A Prospective, Observational Cohort Study.
    Cho JH; Yoon YD; Jang HM; Kwon E; Jung HY; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Won DI; Kim CD
    Medicine (Baltimore); 2015 Nov; 94(44):e1902. PubMed ID: 26554788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expansion of regulatory CD8+ T-lymphocytes and fall of activated CD8+ T-lymphocytes after i.v. methyl-prednisolone for multiple sclerosis relapse.
    Aristimuño C; Navarro J; de Andrés C; Martínez-Ginés L; Giménez-Roldán S; Fernández-Cruz E; Sánchez-Ramón S
    J Neuroimmunol; 2008 Nov; 204(1-2):131-5. PubMed ID: 18835045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrolysed-reduced water dialysate improves T-cell damage in end-stage renal disease patients with chronic haemodialysis.
    Huang KC; Hsu SP; Yang CC; Ou-Yang P; Lee KT; Morisawa S; Otsubo K; Chien CT
    Nephrol Dial Transplant; 2010 Aug; 25(8):2730-7. PubMed ID: 20190245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.